BEIJING (Reuters): China has given conditional approval for general public use for a Covid-19 vaccine developed by state-owned drug maker Sinopharm, an official with China's National Medical Products Administration told a media briefing on Thursday (Dec 31).
The approval of the vaccine developed by Sinopharm's China National Biotec Group (CNBG) affiliate is the first for general public use among a handful of Chinese coronavirus vaccine candidates in various stages of trials.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
